Sofosbuvir/Velpatasvir for 12 Weeks in Hepatitis C Virus-Infected Patients with End-Stage Renal Disease Undergoing Dialysis
June 2019
Author(s): Borgia SM, Dearden J, Yoshida EM, Shafran SD, Brown A, Ben-Ari Z, et al
Details: J Hepatol. 2019
NIHR Acknowledged: Yes
People
Photo | Name | Bio |
---|